, Volume 31, Issue 1–2, pp 9–27 | Cite as

Monoclonal antibodies against naturally occurring bioactive compounds

  • Yukihiro Shoyama
  • Hiroyuki Tanaka
  • Noriko Fukuda


The ratio of hapten to bovine serum albumin (BSA) in an antigen conjugate was determined by matrix-assisted laser desorption/ionization (MALDI) tof mass spectrometry. A hybridoma secreting monoclonal antibody (MAb) was produced by fusing splenocytes immunized with an antigen-BSA conjugate with HAT-sensitive mouse myeloma cells. The cross-reaction of anti-forskolin antibodies with 7-deacetyl forskolin was 5.6%. A very small cross-reaction appeared with other derivatives. The full measuring range of the assay extends from 5 ng to 5 μg/ml of forskolin. Immunoaffinity column chromatography using anti-forskolin MAbs appears to be far superior to previously published separation methods. The capacity of the immunoaffinity column as determined by ELISA is 9 μg/ml. Forskolin has been isolated directly from the crude extracts of tuberous roots and the callus culture of Coleus forskohlii. A MAb against tetrahydrocannabinolic acid (THCA) was produced. The cross-reaction of anti-THCA antibody against other cannabinoids was very wide. Many cannabinoids and a spiro-compound were reactive, but did not react with other phenolics. It became evident that this ELISA was able to be applied to the biotransformation experiments of cannabinoids in plant tissue culture system. Anti-ginsenoside Rb1 MAbs were produced. New western blotting method of determination for ginsenosides was established. Ginsenosides separated by silica gel TLC were transferred to a polyvinylidene difluoride (PVDF) membrane. The membrane was treated with NaIO4 solution followed by BSA, resulting in a ginsenoside-BSA conjugate. Immunostaining of ginsenosides was more sensitive compared to other staining. Immunostaining of ginsenosides in the fresh ginseng root was succeeded using anti-ginsenoside Rb1 (GRb1) MAb after blotting to PVDF membrane.

cannabino ELISA forskolin idmonoclonal antibody monoclonal antibody western blotting 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Bhat SV, Bajwa BS, Dornauer H, de Sousa NJ and Fehlhabar HW (1977) Structures and stereochemistry of new labdane diterpenoids from Coleus forskohlii Briq. Tetrahedron Letters: 1669–1672.Google Scholar
  2. Burstein SH (1973) Labelling and metabolism of the tetrahydrocannabinols. In: Mechoulam, R. (Ed.) Marihuana, Chemistry, Pharmacology, Metabolism, and Clinical Effects, Academic Press, New York, London, pp. 167–190.Google Scholar
  3. Cais M, Dani S, Josephy Y, Modiano A, Gershon H and Mechoulam R (1975) Studies of cannabinoid metabolites-free radical immunoassay. FEBS Letters 55: 257–260.CrossRefGoogle Scholar
  4. Devane WA, Hanus L, Breuer A, Pertwee RG, Stevenson LA, Griffing G, Gibson D, Mandelbaum A, Etinger A and Mechoulam R (1992) Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 258: 1946–1949.Google Scholar
  5. Gabetta B, Zini G and Danieli B (1989) Minor diterpenoids of Coleus forskohlii. Phytochemistry 28: 859–862.CrossRefGoogle Scholar
  6. Goto Y, Shima Y, Morimoto S, Shoyama Y, Murakami H, Kusai A and Nojima K (1994) Determination of tetrahydrocannabinolic acid-carrier protein conjugate by matrix-assisted laser desorption/ionization mass spectrometry and antibody formation. Org Mass Spectrum 29: 668–671.CrossRefGoogle Scholar
  7. Gross SJ, Soares JR, Wong SL and Schuster RE (1974) Marihuana metabolites measured by a radioimmune technique. Nature 252: 581–582.CrossRefGoogle Scholar
  8. Ho LT and Ho RJ (1987) Production and assay of antibodies to an activator of adenylate cyclase, forskolin. J Cyclic Nucletide Protein Phosphorylation Res 11: 421–432.Google Scholar
  9. Inamdar PK, Dornauer H and de Souza NJ (1980) GLC method for assay of forskolin, a novel positive inotropic and blood pressure-lowering agent. J Pharm Sci 69: 1449–1451.Google Scholar
  10. Inamdar PK, Kanitkar PV, Reden J and de Souza NJ (1984) Quantitative determination of forskolin by TLC and HPLC. Planta Medica 51: 30–34.Google Scholar
  11. Ishiyama M, Shoyama Y, Murakami H and Shinohara H (1996) Production of monoclonal antibodies and development of an ELISA for solamargine. Cytotechnology 18: 153–158.CrossRefGoogle Scholar
  12. Krombholz M, Mersinger R, Kreis W and Reinhard E (1992) Production of forskolin by axenic Coleus forskohlii roots cultivated in shake flasks and 20-l glass jar bioreactors. Planta Medica 58: 328–333.Google Scholar
  13. Langone JJ (1982) Use of protein A to remove immunoglobulins from serum in hybridoma culture media. J Immunol Meth 51: 33–45.CrossRefGoogle Scholar
  14. Lewis GS and Turner CE (1990) Constituents of Cannabis sativa L. XIII: Stability of dosage from prepared by impregnating synthetic (-)-Δ9-trans-tetrahydrocannabinol on placebo Cannabis plant material. J Pharm Sci 67: 876–878.Google Scholar
  15. Matsuda LA, Lolait SJ, Brownstein MJ, Young AC and Bonner TI (1990) Structure of a cannabinoid receptor and functional expression of the cDNA. Nature 346: 561–564.CrossRefGoogle Scholar
  16. Mersinger R, Dornauer H and Reinhard E (1988) Formation of forskolin by suspension cultures of Coleus forskohlii. Planta Medica 54: 200–204.Google Scholar
  17. Metzger H and Lindner E (1981) The positive inotropic-acting forskolin, a potent adenylatecyclase activator. Drug Research 31: 1248–1250.Google Scholar
  18. Miller IJ, McCallus NK, Kirk CM and Peake BM (1982) The free radical oxidation of the tetrahydrocannabinols. Experimentia 38: 230–232.CrossRefGoogle Scholar
  19. Morimoto S, Komatsu K, Taura F and Shoyama Y (1997) Enzymological evidence for cannabichromenic acid biosynthesis. J Nat Prod 60: 854–857.CrossRefGoogle Scholar
  20. Okada M, Urae A, Mine K, Shoyama Y, Iwasaki K and Fujiwara M (1992) The facilitating and suppressing effects of delta-9-tetrahydrocannabinol on the rise in intrasynaptosomal Ca2+ concentration in rats. Neurosci Lett 140: 55–58.CrossRefGoogle Scholar
  21. Razdan RK, Puttick AJ, Zitko BA and Handrick GR (1972) Hashish VI: Conversion of (-)-Δ1(6)-tetrahydrocannabinol to (-)-Δ1(7)-tetrahydrocannabinol. Stability of (-)-Δ1 and (-)-Δ1(6)-tetrahydrocanabinols. Experientia 28: 121–123.CrossRefGoogle Scholar
  22. Reed RG, Putnam FW and Peters Jr, T (1980) Sequence of residues 400–403 of bovine serum albumin. Biochem J 191: 867–868.Google Scholar
  23. Sakata R, Shoyama Y and Murakami H (1994) Production of monoclonal antibodies and enzyme immunoassay for typical adenylate cyclase activator, forskolin. Cytotechnology 16: 101–108.CrossRefGoogle Scholar
  24. Sen J, Sharma AK, Sahu NP and Mahato SB (1992) Production of forskolin in in vitro cultures of Coleus forskohlii. Planta Medica 58: 324–327.Google Scholar
  25. Shah V, Bhat SV, Bajwa BS, Dornauer H and de Souza NJ (1980) The occurrence of forskolin in the Labiatae. Planta Medica 39: 183–185.CrossRefGoogle Scholar
  26. Shoyama Y, Yamauchi T and Nishioka I (1970) Cannabis V. Cannabigerolic acid monomethyl ether and cannabinolic acid. Chem Pharm Bull 18: 1327–1332.Google Scholar
  27. Shoyama Y, Hirano H, Makino H, Umekita N and Nishioka I (1977) Cannabis X. The isolation and structures of four new propyl cannabinoid acids, tetrahydrocannabivarinic acid, cannabidivarinic acid, cannabichromevarinic acid and cannabigerovarinic acid, from Thai Cannabis, Meao variant. Chem Pharm Bull 25: 2306–2311.Google Scholar
  28. Shoyama Y and Nishioka I (1978) Cannabis XIII. Two new spiro-compounds, cannabispirol and acetyl cannabispirol. Chem Pharm Bull 26: 3641–3646.Google Scholar
  29. Shoyama Y, Hirano H and Nishioka I (1984) Biosynthesis of propyl cannabinoid acid and its biosynthetic relationship with pentyl and methyl cannabinoid acids. Phytochemistry 23: 1909–1912.CrossRefGoogle Scholar
  30. Shoyama Y (1993) Biological aspects on marihuana, Cannabis sativa L. and biotechnological investigation on medicinal plants. In: Okubo, H. (Ed.) Winged bean and some other vegetables and medicinal plants in the tropics and subtropics. Tokushunosanbutsu Kyokai, Tokyo, pp. 141–200.Google Scholar
  31. Shoyama Y, Sakata R, Isobe R and Murakami H (1993) Direct determination of forskolin-bovine serum albumin conjugate by matrix-assisted laser desorption ionization mass spectrometry. Org Mass Spectrum 28: 987–988.CrossRefGoogle Scholar
  32. Taki T, Kasama T, Handa S and Ishikawa D (1994) A simple and quantitative purification of glycosphingolipids and phospholipids by thin-layer chromatography blotting. Anal Biochem 223: 232–238.CrossRefGoogle Scholar
  33. Tanaka H, Morimoto S and Shoyama Y (1993) Cannabis 21. Biotransformation of cannabinol to its glycosides by in vitro plant tissue. J Nat Prod 56: 2068–2072.CrossRefGoogle Scholar
  34. Tanaka H, Takahashi R, Morimoto S and Shoyama Y (1996) Cannabis 25, biotransformation of cannabidiol and cannabidiolic acid by Pinellia ternata tissue segments. Plant Cell Rep 15: 819–823.CrossRefGoogle Scholar
  35. Tanaka H, Takahashi R, Morimoto S and Shoyama Y (1997) A new cannabinoid, Δ6-tetrahydrocannabinol 2′-O-β-D-glucopyranoside, biotransformed by plant tissue. J Nat Prod 60: 168–170.CrossRefGoogle Scholar
  36. Tanaka H, Putalun W, Tsuzaki C and Shoyama Y (1997) A simple determination of steroidal alkaloid glycosides by thin-layer chromatography immunostaining using monoclonal antibody against solamargine. FEBS Lett 404: 279–282.CrossRefGoogle Scholar
  37. Taura F, Morimoto S, Shoyama Y and Mechoulam R (1995) First direct evidence for the mechanism of delta1-tetrahydrocannabinolic acid biosynthesis. J Am Chem Soc 117: 9766–9767.CrossRefGoogle Scholar
  38. Taura F, Morimoto S and Shoyama, Y (1996) Purification and characterization of cannabidiolic acid synthase from Cannabis sativa L. J Biol Chem 271: 17411–17416.CrossRefGoogle Scholar
  39. Teale JD, Forman EJ, King LJ and Marks V (1974) Production of antibodies to tetrahydrocannabinol as the basis for its radioimmunoassay. Nature 249: 154–155.CrossRefGoogle Scholar
  40. Teale JD, Forman E J, King LJ, Piall EM and Marks V (1975) The development of a radioimmunoassay for cannabinoids in blood and urine. J Pharm Pharmacol 27: 465–472.Google Scholar
  41. Vishwakarma RA, Tyagi BR, Ahmed B and Husain A (1988) Variation in forskolin content in the roots of Coleus forskohlii. Planta Medica 57: 471–472.Google Scholar
  42. Weiler EW and Zenk MH (1976) Radioimmunoassay for the determination of digoxin and related compounds in Digitalis lanata. Phytochemistry 15: 1537–1545.CrossRefGoogle Scholar
  43. Yanagihara H, Sakata R, Minami H, Tanaka H, Shoyama Y and Murakami H (1996) Immunoaffinity column chromatography against forskolin using an anti-forskolin monoclonal antibody and its application. Anal Chim Acta 335: 63–70.CrossRefGoogle Scholar
  44. Yanagihara H, Sakata R, Shoyama Y and Murakami H (1996) Rapid analysis of small samples containing forskolin using monoclonal antibodies. Planta Medica 62: 169–172.Google Scholar
  45. Yamamoto I (1986) Metabolic activation of marihuana constituent. Yakugaku Zasshi 106: 537–561.Google Scholar
  46. Yamauchi T, Shoyama Y, Azuma T and Nishioka I (1967) Tetrahydrocannabinolic acid, a genuine substance of tetrahydrocannabinol. Chem Pharm Bull 15: 1975–1976.Google Scholar

Copyright information

© Kluwer Academic Publishers 1999

Authors and Affiliations

  • Yukihiro Shoyama
  • Hiroyuki Tanaka
  • Noriko Fukuda

There are no affiliations available

Personalised recommendations